Media

MEDIA ENQUIRIES CONTACT

Media | Michelle Henderson
m: +61 0 417 765 311
ecommunications@hudson.org.au

Media | Ann Pukallus
m: +61 0 457 552 530
ecommunications@hudson.org.au

In the media 2020

September

Hidden immune weakness found in 14% of gravely ill COVID-19 patients
Science Magazine

Hudson Institute recognised for its commitment to workplace health and wellbeing
Australasian Leisure Management

Lab discovery could help fight deadly Ovarian cancer
TV | Channel 9
Radio | 2GB Sydney
Radio | 5AA Adelaide
9news

Melbourne researchers get backing for potential ovarian cancer treatment
Health Dispatch
Biotech Dispatch

August


Securing The Future of Regenerative Medicine In Victoria
Premier of Victoria

Backing Victoria’s Next Big Medical Breakthroughs
Premier of Victoria

Ovarian cancer is a silent killer and there’s a renewed push for funding and research to find an early-detection test
The Courier

Urgent government funding is needed for effective, diverse and equitable medical research
Womens Agenda

Could a hormone help spur high blood pressure?
Health24

First review of SARS-CoV-2 and COVID-19 infection models
Scimex
7thSpace

COVID-19 deaths more common in men due to health system imbalance
Adelaide Now

Impact Analysis of Covid-19
Pharmiweb

Bacteria’s secret weapon revealed
EurekaAlert
Scimex

One in 10 women are affected by endometriosis. So why does it take so long to diagnose?
The Conversation
sbs.com.au
viw.com.au
Womens Agenda
The Mandarin

Why Victoria should brace for 40 COVID-19 deaths a day – Dr Michael Gantier
Herald Sun

Young swept up in new virus wave – Dr Michael Gantier
Herald Sun

Securing Future Of Regenerative Medicine In Victoria
Mirage News

Backing Victoria’s next big medical breakthroughs
Get Regional

July

$2.2M  Awarded to Collaboration Researching rare Form of Ovarian Cancer
Ovarian Cancer News Today

20 PhDs in 20 Minutes – Dr Shane is joined by Dr Erin McGillick
3RRR FM

20 PhDs in 20 Minutes – Dr Shane is joined by Dr Vanesa Stojanovska
3RRR FM

June

Resurgence in COVID-19 cases in Victoria. Dr Michelle Tate comments.
ABC radio

Anti-cancer drug to undergo trials for coronavirus patients
Herald Sun
Daily Telegraph
NT News
Townsville Bulletin
The Mercury
Geelong Advertiser
The Courier Mail
The Advertiser
Perth Now
News.Com

Testosterone to prevent type 2 diabetes in men
Mirage News

May

Could a Hormone Help Spur High Blood Pressure?
US News

Noxopharm receives FDA green light to progress towards Veyonda® trial
Kalkine Media
Finfeed
The Market Herald
Biotech Dispatch

Massive Australian Effort to beat coronavirus
Association of Australian Medical Research Institutes
The Courier-Mail

Reduce Tumor Activity in Breast Cancer
Targeted Oncology

Noxopharm marks important breakthroughs
The Market Herald

April

Request for approval from US FDA for clinical trials on COVID-19 patients
TechInvest
Mirage News
PharmaShots
Small Caps
The Market Herald
Kalkine Media

Eureka Research Fund for Immunology and Virology launched
Financial Review

The next pandemic: Firebreaks and host-directed therapies
Bio World

Tumor-fighting laser might also trigger an immune response in the body
Stockhead
Invion

Cancer drug investigated as anti-inflammatory for lethal conditions including COVID-19
Kalkine Media
Yahoo Finance
Business Wire
Small Caps
Morning Star
Reuters
Finance News Network
The National Tribune
Australian Manufacturing Forum
Mirage News
Small Caps

March

Coronavirus progress: Breakthrough research, first human vaccine trial
RACGP (Royal Australian College of General Practitioners)

February

Simple blood test measures the body’s immune response to improve ovarian cancer diagnosis
News Medical
Retail Pharmacy
Health Times
Biotech


January

Interview with Tasha Amour, CEO, Rare Ovarian Cancer Inc. 
ABC Illawarra, Wollongong

Edgar a stalwart of banking sector and proud humanitarian
The Australian

IVF treatment breakthroughs to create miracle babies
Herald Sun
Daily Telegraph Australia
Cairns Post
Gold Coast Bulletin
Northern Territory News
Adelaide Now
The Courier Mail

In the Media section